We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cambridge Nutritional Sciences Plc | LSE:CNSL | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.85 | 623,930 | 07:34:23 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 3.70 | 4.00 | 3.85 | 3.85 | 3.85 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices-holdng Companies,nec | 8.19M | -3.86M | -0.0162 | -2.38 | 9.15M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:22:30 | O | 150,000 | 3.87 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/4/2024 | 10:09 | ALNC |  Cambridge Nutritional Sciences shares jump on expected revenue boost |
| 22/4/2024 | 08:21 | UK RNS | Cambridge Nutritional Sciences PLC Trading Update and Directorate Change |
| 03/4/2024 | 07:00 | UK RNS | Cambridge Nutritional Sciences PLC Q2 2024 Industry Events Schedule |
| 30/1/2024 | 12:50 | UK RNS | Cambridge Nutritional Sciences PLC Issue of Equity and Total Voting Rights |
| 29/1/2024 | 21:25 | ALNC | IN BRIEF: Cambridge Nutritional Sciences hires first operations chief |
| 29/1/2024 | 07:00 | UK RNS | Cambridge Nutritional Sciences PLC Appointment of Operations Director |
| 22/1/2024 | 07:00 | RNSNON | Cambridge Nutritional Sciences PLC Scientific Educational Webinar and.. |
| 18/12/2023 | 15:51 | UKREG | Cambridge Nutritional Sciences PLC Holding(s) in Company |
| 04/12/2023 | 19:53 | ALNC | IN BRIEF: Cambridge Nutritional Sciences develops education programme |
| 04/12/2023 | 07:00 | RNSNON | Cambridge Nutritional Sciences PLC Scientific Educational Programme.. |
Cambridge Nutritional Sc... (CNSL) Share Charts1 Year Cambridge Nutritional Sc... Chart |
|
1 Month Cambridge Nutritional Sc... Chart |
Intraday Cambridge Nutritional Sc... Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/4/2024 | 16:25 | Cambridge Nutritional Sciences: Ex Omega Diagnostics (ODX) | 205 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-04-26 15:22:31 | 3.87 | 150,000 | 5,805.00 | O |
| 2024-04-26 15:21:20 | 3.88 | 12,896 | 499.98 | O |
| 2024-04-26 15:08:19 | 3.85 | 250,000 | 9,625.00 | O |
| 2024-04-26 14:28:14 | 3.88 | 568 | 22.02 | O |
| 2024-04-26 14:20:02 | 3.77 | 158 | 5.95 | O |
| Top Posts |
|---|
Posted at 26/4/2024 09:20 by Cambridge Nutritional Sc... Daily Update Cambridge Nutritional Sciences Plc is listed in the Offices-holdng Companies,nec sector of the London Stock Exchange with ticker CNSL. The last closing price for Cambridge Nutritional Sc... was 3.85p.Cambridge Nutritional Sc... currently has 237,685,180 shares in issue. The market capitalisation of Cambridge Nutritional Sc... is £9,150,879. Cambridge Nutritional Sc... has a price to earnings ratio (PE ratio) of -2.38. This morning CNSL shares opened at 3.85p |
Posted at 22/4/2024 21:56 by wbodger Understandable they want a premium for 150,000 shares - CNSL could be a bid target and there are only 237 million shares in issue. I'm surprised there is any market at 3.7p at all, mid price, because that only equates to a £9 million market cap. That's derisory.If Cavendish can't get the share price higher shame on them. The LSE is in trouble because financial advisors and Nomads get paid for getting companies sold at stupid prices. That's the clear danger here - lowball takeover. Companies that don't buy back their own shares when they are under shorting attack get taken over for peanuts. CNSL has cash, if their advisor thinks market cap should be £23 million use some of the cash to buy back shares. That's what I do if I can buy £10 notes for a fiver. |
Posted at 22/4/2024 12:21 by thecoyone My understanding is it is being strongly contested and CNSL have also put in what they describe as a very significant counter claim.CNSL legal advice implies they have no liability to repay it, on the contrary in fact. The Gov have not been responding to CNSL so that in itself is a sign they (the Gov) are potentially liable to pay damages, I have followed this matter extensively. So far the new team at CNSL have hardly put a foot out of place. |
Posted at 22/4/2024 08:14 by yasxii GentlemenHas it dawned on holders/followers of this outfit that company silence can only be deemed as exceptionally positive, it clearly suggests they are well on target to meet market expectations, this is very good news indeed. The next operations statement is not a million miles away, remember the market is forward looking, the timeline to acquire a meaningful tranche of stock is limited. Does the Gracious Fellow believe the share price will be in double digits by year end, the answer is a very definite yes. Those broker targets of 10p to 12p remain and quite rightly so. |
Posted at 26/3/2024 12:16 by broken_arrow1 Can confirm IG are struggling to get fixed buyside prices in CNSL, currently they are asking a premium for just under £5k of sharesEarlier it was not possible to trade CNSL on their platform for a period. |
Posted at 20/3/2024 14:27 by rivaldo Good to see the share price breaking upwards and out of its shackles.Still loads of upside from here imo. |
Posted at 15/3/2024 07:55 by thecoyone Looks like the CEO (4th from left seated) has been doing some discreet promotion in the City, possibly explains the increased interest here.With circa £4.5m in the bank, a market cap of only £6.75m, growing £10m+ revenues & higher margins no wonder the share price is moving up |
Posted at 14/3/2024 08:11 by thecoyone Results today from Abingdon Health show the sector is returning back to health, this has to be good for all participants, especially the smaller companies whose share prices have been battered down.I think CNSL is one of the best plays for capital appreciation in the sector starting from a very low base, their cash position is exceptional around £4m, how many AIM listed outfits would like that number in their bank. If all goes to plan I expect to see the share price above 10p by year end, my only concern, as mentioned before, is a low ball takeover approach but the BOD have stated it would need to be at a significant premium to market to be considered. Fact is the shares are cheap (£6.5m m/cap), very cheap, no wonder it is very difficult to get a meaningful slice. |
Posted at 13/3/2024 07:53 by broken_arrow1 Someone took 125k right at the close and took all the remaining stock on offer at 3p.Looks like the share price strength will continue today therefore. That 3.75p chart gap still needs filling, possibly today. |
Posted at 12/3/2024 15:04 by one2go Not seen YasXII for a while but this post was from December, he is a strong bull of CNSLyasXII - 11 Dec 2023 - 14:47:52 - 73 of 112 Cambridge Nutritional Sciences - CNSL Remember fools and money are easily parted, some may be happy with a modest trading profit but the real money is made by the patient. The Gracious Fellow draws attention to a fair period of share price consolidation over recent weeks but the prudent are buyers in a thin market. Get ready for the next move north, it could be spectacular, some may be happy with 5p a share however that is a minimum view for the experienced eye. Who wants to join the Gracious One on the next ride up ?? |
Posted at 12/3/2024 10:02 by thecoyone I have 500,000 of these and am happy to wait for the obvious re-rate that will come as the company grows into ever expanding markets and value outs, my main concern is a lowball takeover approach.The gut health business worldwide is estimated to be $40b, this company is expanding rapidly and is being totally overlooked by the market so far. It is nigh impossible to buy a large chunk of stock at any time so the best option is to gradually acquire. If all goes to plan I see a share price north of 10p by year end, even then the company would only be valued at £23m. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
